17 results on '"Shih, Natalie N. C."'
Search Results
2. Prognostic correlations with the microbiome of breast cancer subtypes
- Author
-
Banerjee, Sagarika, Wei, Zhi, Tian, Tian, Bose, Dipayan, Shih, Natalie N. C., Feldman, Michael D., Khoury, Thaer, De Michele, Angela, and Robertson, Erle S.
- Published
- 2021
- Full Text
- View/download PDF
3. Risk Factors for gyrA and parC Mutations in Pseudomonas aeruginosa
- Author
-
Cluzet, Valerie C., Lautenbach, Ebbing, Nachamkin, Irving, Cary, Mark S., Fishman, Neil O., Shih, Natalie N. C., Morales, Knashawn H., and Linkin, Darren R.
- Published
- 2015
- Full Text
- View/download PDF
4. Stable and discriminating features are predictive of cancer presence and Gleason grade in radical prostatectomy specimens: a multi-site study
- Author
-
Leo, Patrick, primary, Elliott, Robin, additional, Shih, Natalie N. C., additional, Gupta, Sanjay, additional, Feldman, Michael, additional, and Madabhushi, Anant, additional
- Published
- 2018
- Full Text
- View/download PDF
5. Evaluating stability of histomorphometric features across scanner and staining variations: prostate cancer diagnosis from whole slide images
- Author
-
Leo, Patrick, primary, Lee, George, additional, Shih, Natalie N. C., additional, Elliott, Robin, additional, Feldman, Michael D., additional, and Madabhushi, Anant, additional
- Published
- 2016
- Full Text
- View/download PDF
6. Self-renewal of CD133hi cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer
- Author
-
Sansone, Pasquale, primary, Ceccarelli, Claudio, additional, Berishaj, Marjan, additional, Chang, Qing, additional, Rajasekhar, Vinagolu K., additional, Perna, Fabiana, additional, Bowman, Robert L., additional, Vidone, Michele, additional, Daly, Laura, additional, Nnoli, Jennifer, additional, Santini, Donatella, additional, Taffurelli, Mario, additional, Shih, Natalie N. C., additional, Feldman, Michael, additional, Mao, Jun J., additional, Colameco, Christopher, additional, Chen, Jinbo, additional, DeMichele, Angela, additional, Fabbri, Nicola, additional, Healey, John H., additional, Cricca, Monica, additional, Gasparre, Giuseppe, additional, Lyden, David, additional, Bonafé, Massimiliano, additional, and Bromberg, Jacqueline, additional
- Published
- 2016
- Full Text
- View/download PDF
7. Supervised Multi-View Canonical Correlation Analysis (sMVCCA): Integrating Histologic and Proteomic Features for Predicting Recurrent Prostate Cancer
- Author
-
Lee, George, primary, Singanamalli, Asha, additional, Wang, Haibo, additional, Feldman, Michael D., additional, Master, Stephen R., additional, Shih, Natalie N. C., additional, Spangler, Elaine, additional, Rebbeck, Timothy, additional, Tomaszewski, John E., additional, and Madabhushi, Anant, additional
- Published
- 2015
- Full Text
- View/download PDF
8. Co-Occurring Gland Angularity in Localized Subgraphs: Predicting Biochemical Recurrence in Intermediate-Risk Prostate Cancer Patients
- Author
-
Lee, George, primary, Sparks, Rachel, additional, Ali, Sahirzeeshan, additional, Shih, Natalie N. C., additional, Feldman, Michael D., additional, Spangler, Elaine, additional, Rebbeck, Timothy, additional, Tomaszewski, John E., additional, and Madabhushi, Anant, additional
- Published
- 2014
- Full Text
- View/download PDF
9. Risk Factors for gyrAand parCMutations in Pseudomonas aeruginosa
- Author
-
Cluzet, Valerie C., Lautenbach, Ebbing, Nachamkin, Irving, Cary, Mark S., Fishman, Neil O., Shih, Natalie N. C., Morales, Knashawn H., and Linkin, Darren R.
- Abstract
OBJECTIVEThe major mechanism of fluoroquinolone (FQ) resistance in Pseudomonas aeruginosa(PSA) is modification of target proteins in DNA gyrase and topoisomerase IV, most commonly the gyrAand parCsubunits. The objective of this study was to determine risk factors for PSA with and without gyrAor parCmutations.DESIGNCase-case-control studySETTINGTwo adult academic acute-care hospitalsPATIENTSCase 1 study participants had a PSA isolate on hospital day 3 or later with any gyrAor parCmutation; case 2 study participants had a PSA isolate on hospital day 3 or later without these mutations. Controls were a random sample of all inpatients with a stay of 3 days or more.METHODSEach case group was compared to the control group in separate multivariate models on the basis of demographics and inpatient antibiotic exposure, and risk factors were qualitatively compared.RESULTSOf 298 PSA isolates, 172 (57.7%) had at least 1 mutation. Exposure to vancomycin and other agents with extended Gram-positive activity was a risk factor for both cases (case 1 odds ratio [OR], 1.09; 95% confidence interval [CI], 1.04–1.13; OR, 1.14; 95% CI, 1.03–1.26; case 2 OR, 1.09; 95% CI, 1.03–1.14; OR, 1.13; 95% CI, 1.01–1.25, respectively).CONCLUSIONSExposure to agents with extended Gram-positive activity is a risk factor for isolation of PSA overall but not for gyrA/parCmutations. FQ exposure is not associated with isolation of PSA with mutations.Infect Control Hosp Epidemiol2015;00(0): 1–7
- Published
- 2015
- Full Text
- View/download PDF
10. Self-renewal of CD133hi cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer.
- Author
-
Sansone, Pasquale, Ceccarelli, Claudio, Berishaj, Marjan, Chang, Qing, Rajasekhar, Vinagolu K., Perna, Fabiana, Bowman, Robert L., Vidone, Michele, Daly, Laura, Nnoli, Jennifer, Santini, Donatella, Taffurelli, Mario, Shih, Natalie N. C., Feldman, Michael, Mao, Jun J., Colameco, Christopher, Chen, Jinbo, DeMichele, Angela, Fabbri, Nicola, and Healey, John H.
- Published
- 2016
- Full Text
- View/download PDF
11. Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targets.
- Author
-
Paul, Matt R., Tien-chi Pan, Pant, Dhruv K., Shih, Natalie N. C., Yan Chen, Harvey, Kyra L., Solomon, Aaron, Lieberman, David, Morrissette, Jennifer J. D., Soucier-Ernst, Danielle, Goodman, Noah G., Stavropoulos, S. William, Maxwell, Kara N., Clark, Candace, Belka, George K., Feldman, Michael, DeMichele, Angela, Chodosh, Lewis A., Pan, Tien-Chi, and Shih, Natalie Nc
- Subjects
- *
METASTATIC breast cancer , *PROGESTERONE receptors , *FOCAL adhesions , *ESTROGEN receptors , *WNT signal transduction , *TRIPLE-negative breast cancer , *PROTEINS , *RESEARCH , *GENETIC mutation , *RESEARCH methodology , *METASTASIS , *EVALUATION research , *MEDICAL cooperation , *CELLULAR signal transduction , *COMPARATIVE studies , *GENES , *RESEARCH funding , *BREAST tumors - Abstract
Nearly all breast cancer deaths result from metastatic disease. Despite this, the genomic events that drive metastatic recurrence are poorly understood. We performed whole-exome and shallow whole-genome sequencing to identify genes and pathways preferentially mutated or copy-number altered in metastases compared with the paired primary tumors from which they arose. Seven genes were preferentially mutated in metastases - MYLK, PEAK1, SLC2A4RG, EVC2, XIRP2, PALB2, and ESR1 - 5 of which are not significantly mutated in any type of human primary cancer. Four regions were preferentially copy-number altered: loss of STK11 and CDKN2A/B, as well as gain of PTK6 and the membrane-bound progesterone receptor, PAQR8. PAQR8 gain was mutually exclusive with mutations in the nuclear estrogen and progesterone receptors, suggesting a role in treatment resistance. Several pathways were preferentially mutated or altered in metastases, including mTOR, CDK/RB, cAMP/PKA, WNT, HKMT, and focal adhesion. Immunohistochemical analyses revealed that metastases preferentially inactivate pRB, upregulate the mTORC1 and WNT signaling pathways, and exhibit nuclear localization of activated PKA. Our findings identify multiple therapeutic targets in metastatic recurrence that are not significantly mutated in primary cancers, implicate membrane progesterone signaling and nuclear PKA in metastatic recurrence, and provide genomic bases for the efficacy of mTORC1, CDK4/6, and PARP inhibitors in metastatic breast cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
12. Self-renewal of CD133(hi) cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer
- Author
-
Monica Cricca, Jennifer Nnoli, John H. Healey, Claudio Ceccarelli, Angela DeMichele, Michele Vidone, Jun J. Mao, Jacqueline Bromberg, Christopher Colameco, Marjan Berishaj, Michael Feldman, Vinagolu K. Rajasekhar, Nicola Fabbri, Natalie N. C. Shih, David Lyden, Laura Daly, Pasquale Sansone, Robert L. Bowman, Massimiliano Bonafè, Giuseppe Gasparre, Fabiana Perna, Mario Taffurelli, Qing Chang, Donatella Santini, Jinbo Chen, Sansone, Pasquale, Ceccarelli, Claudio, Berishaj, Marjan, Chang, Qing, Rajasekhar, Vinagolu K, Perna, Fabiana, Bowman, Robert L, Vidone, Michele, Daly, Laura, Nnoli, Jennifer, Santini, Donatella, Taffurelli, Mario, Shih, Natalie N C, Feldman, Michael, Mao, Jun J, Colameco, Christopher, Chen, Jinbo, Demichele, Angela, Fabbri, Nicola, Healey, John H, Cricca, Monica, Gasparre, Giuseppe, Lyden, David, Bonafé, Massimiliano, and Bromberg, Jacqueline
- Subjects
0301 basic medicine ,medicine.medical_treatment ,General Physics and Astronomy ,Mice, SCID ,self-renewal ,Oxidative Phosphorylation ,Targeted therapy ,0302 clinical medicine ,Mice, Inbred NOD ,Medicine ,AC133 Antigen ,CD133 ,Cell Self Renewal ,Neoplasm Metastasis ,Fulvestrant ,Receptor, Notch3 ,Multidisciplinary ,Estradiol ,Receptors, Notch ,Carcinoma, Ductal, Breast ,Flow Cytometry ,Metastatic breast cancer ,3. Good health ,Gene Expression Regulation, Neoplastic ,Receptors, Estrogen ,030220 oncology & carcinogenesis ,Letrozole ,MCF-7 Cells ,Neoplastic Stem Cells ,Hormonal therapy ,Female ,metastatic breast cancer ,Signal Transduction ,medicine.drug ,medicine.medical_specialty ,Notch ,Antineoplastic Agents, Hormonal ,Science ,Bone Neoplasms ,Breast Neoplasms ,Anastrozole ,In Vitro Techniques ,Real-Time Polymerase Chain Reaction ,Article ,General Biochemistry, Genetics and Molecular Biology ,resistance ,03 medical and health sciences ,Breast cancer ,Antigens, CD ,Cancer stem cell ,Cell Line, Tumor ,Internal medicine ,Nitriles ,Animals ,Humans ,Glycoproteins ,Interleukin-6 ,business.industry ,General Chemistry ,Triazoles ,medicine.disease ,IL6 ,Androstadienes ,Carcinoma, Lobular ,Tamoxifen ,030104 developmental biology ,Endocrinology ,Drug Resistance, Neoplasm ,Cancer cell ,Cancer research ,Leuprolide ,Peptides ,business ,Neoplasm Transplantation - Abstract
The mechanisms of metastatic progression from hormonal therapy (HT) are largely unknown in luminal breast cancer. Here we demonstrate the enrichment of CD133hi/ERlo cancer cells in clinical specimens following neoadjuvant endocrine therapy and in HT refractory metastatic disease. We develop experimental models of metastatic luminal breast cancer and demonstrate that HT can promote the generation of HT-resistant, self-renewing CD133hi/ERlo/IL6hi cancer stem cells (CSCs). HT initially abrogates oxidative phosphorylation (OXPHOS) generating self-renewal-deficient cancer cells, CD133hi/ERlo/OXPHOSlo. These cells exit metabolic dormancy via an IL6-driven feed-forward ERlo-IL6hi-Notchhi loop, activating OXPHOS, in the absence of ER activity. The inhibition of IL6R/IL6-Notch pathways switches the self-renewal of CD133hi CSCs, from an IL6/Notch-dependent one to an ER-dependent one, through the re-expression of ER. Thus, HT induces an OXPHOS metabolic editing of luminal breast cancers, paradoxically establishing HT-driven self-renewal of dormant CD133hi/ERlo cells mediating metastatic progression, which is sensitive to dual targeted therapy., ER+ breast cancer patients treated with endocrine therapies often acquire resistance and develop metastasis. In this study, the authors demonstrate that endocrine therapies can promote the self-renewal of CD133hi/ERlo drug resistant cells with metastatic potential driven through the IL6-Notch3 axis activation.
- Published
- 2016
13. Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2.
- Author
-
Leo P, Chandramouli S, Farré X, Elliott R, Janowczyk A, Bera K, Fu P, Janaki N, El-Fahmawi A, Shahait M, Kim J, Lee D, Yamoah K, Rebbeck TR, Khani F, Robinson BD, Shih NNC, Feldman M, Gupta S, McKenney J, Lal P, and Madabhushi A
- Subjects
- Eosine Yellowish-(YS), Hematoxylin, Humans, Male, Neoplasm Recurrence, Local pathology, Prognosis, Prostatectomy methods, Prostate pathology, Prostatic Neoplasms pathology, Prostatic Neoplasms surgery
- Abstract
Background: The presence of invasive cribriform adenocarcinoma (ICC), an expanse of cells containing punched-out lumina uninterrupted by stroma, in radical prostatectomy (RP) specimens has been associated with biochemical recurrence (BCR). However, ICC identification has only moderate inter-reviewer agreement., Objective: To investigate quantitative machine-based assessment of the extent and prognostic utility of ICC, especially within individual Gleason grade groups., Design, Setting, and Participants: A machine learning approach was developed for ICC segmentation using 70 RP patients and validated in a cohort of 749 patients from four sites whose median year of surgery was 2007 and with median follow-up of 28 mo. ICC was segmented on one representative hematoxylin and eosin RP slide per patient and the fraction of tumor area composed of ICC, the cribriform area index (CAI), was measured., Outcome Measurements and Statistical Analysis: The association between CAI and BCR was measured in terms of the concordance index (c index) and hazard ratio (HR)., Results and Limitations: CAI was correlated with BCR (c index 0.62) in the validation set of 411 patients with ICC morphology, especially those with Gleason grade group 2 cancer (n = 192; c index 0.66), and was less prognostic when patients without ICC were included (c index 0.54). A doubling of CAI in the group with ICC morphology was prognostic after controlling for Gleason grade, surgical margin positivity, preoperative prostate-specific antigen level, pathological T stage, and age (HR 1.19, 95% confidence interval 1.03-1.38; p = 0.018)., Conclusions: Automated image analysis and machine learning could provide an objective, quantitative, reproducible, and high-throughput method of quantifying ICC area. The performance of CAI for grade group 2 cancer suggests that for patients with little Gleason 4 pattern, the ICC fraction has a strong prognostic role., Patient Summary: Machine-based measurement of a specific cell pattern (cribriform; sieve-like, with lots of spaces) in images of prostate specimens could improve risk stratification for patients with prostate cancer. In the future, this could help in expanding the criteria for active surveillance., (Copyright © 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
14. Accurate and reproducible invasive breast cancer detection in whole-slide images: A Deep Learning approach for quantifying tumor extent.
- Author
-
Cruz-Roa A, Gilmore H, Basavanhally A, Feldman M, Ganesan S, Shih NNC, Tomaszewski J, González FA, and Madabhushi A
- Subjects
- Adult, Aged, Algorithms, Breast Neoplasms diagnostic imaging, Carcinoma, Ductal, Breast diagnostic imaging, Deep Learning, Female, Humans, Middle Aged, Neoplasm Invasiveness, Tumor Burden, Young Adult, Breast Neoplasms pathology, Carcinoma, Ductal, Breast pathology, Image Interpretation, Computer-Assisted methods
- Abstract
With the increasing ability to routinely and rapidly digitize whole slide images with slide scanners, there has been interest in developing computerized image analysis algorithms for automated detection of disease extent from digital pathology images. The manual identification of presence and extent of breast cancer by a pathologist is critical for patient management for tumor staging and assessing treatment response. However, this process is tedious and subject to inter- and intra-reader variability. For computerized methods to be useful as decision support tools, they need to be resilient to data acquired from different sources, different staining and cutting protocols and different scanners. The objective of this study was to evaluate the accuracy and robustness of a deep learning-based method to automatically identify the extent of invasive tumor on digitized images. Here, we present a new method that employs a convolutional neural network for detecting presence of invasive tumor on whole slide images. Our approach involves training the classifier on nearly 400 exemplars from multiple different sites, and scanners, and then independently validating on almost 200 cases from The Cancer Genome Atlas. Our approach yielded a Dice coefficient of 75.86%, a positive predictive value of 71.62% and a negative predictive value of 96.77% in terms of pixel-by-pixel evaluation compared to manually annotated regions of invasive ductal carcinoma.
- Published
- 2017
- Full Text
- View/download PDF
15. Identifying in vivo DCE MRI markers associated with microvessel architecture and gleason grades of prostate cancer.
- Author
-
Singanamalli A, Rusu M, Sparks RE, Shih NN, Ziober A, Wang LP, Tomaszewski J, Rosen M, Feldman M, and Madabhushi A
- Subjects
- Adult, Aged, Biomarkers, Tumor, Contrast Media, Humans, Image Interpretation, Computer-Assisted methods, Male, Middle Aged, Neoplasm Grading, Pattern Recognition, Automated methods, Prostatic Neoplasms blood supply, Reproducibility of Results, Sensitivity and Specificity, Magnetic Resonance Imaging methods, Microvessels pathology, Neovascularization, Pathologic complications, Neovascularization, Pathologic pathology, Prostatic Neoplasms complications, Prostatic Neoplasms pathology
- Abstract
Background: To identify computer extracted in vivo dynamic contrast enhanced (DCE) MRI markers associated with quantitative histomorphometric (QH) characteristics of microvessels and Gleason scores (GS) in prostate cancer., Methods: This study considered retrospective data from 23 biopsy confirmed prostate cancer patients who underwent 3 Tesla multiparametric MRI before radical prostatectomy (RP). Representative slices from RP specimens were stained with vascular marker CD31. Tumor extent was mapped from RP sections onto DCE MRI using nonlinear registration methods. Seventy-seven microvessel QH features and 18 DCE MRI kinetic features were extracted and evaluated for their ability to distinguish low from intermediate and high GS. The effect of temporal sampling on kinetic features was assessed and correlations between those robust to temporal resolution and microvessel features discriminative of GS were examined., Results: A total of 12 microvessel architectural features were discriminative of low and intermediate/high grade tumors with area under the receiver operating characteristic curve (AUC) > 0.7. These features were most highly correlated with mean washout gradient (WG) (max rho = -0.62). Independent analysis revealed WG to be moderately robust to temporal resolution (intraclass correlation coefficient [ICC] = 0.63) and WG variance, which was poorly correlated with microvessel features, to be predictive of low grade tumors (AUC = 0.77). Enhancement ratio was the most robust (ICC = 0.96) and discriminative (AUC = 0.78) kinetic feature but was moderately correlated with microvessel features (max rho = -0.52)., Conclusion: Computer extracted features of prostate DCE MRI appear to be correlated with microvessel architecture and may be discriminative of low versus intermediate and high GS., (© 2015 Wiley Periodicals, Inc.)
- Published
- 2016
- Full Text
- View/download PDF
16. Computer-extracted Features Can Distinguish Noncancerous Confounding Disease from Prostatic Adenocarcinoma at Multiparametric MR Imaging.
- Author
-
Litjens GJ, Elliott R, Shih NN, Feldman MD, Kobus T, Hulsbergen-van de Kaa C, Barentsz JO, Huisman HJ, and Madabhushi A
- Subjects
- Adenocarcinoma pathology, Adenocarcinoma surgery, Aged, Diagnosis, Differential, Humans, Male, Middle Aged, Prostatectomy, Prostatic Neoplasms pathology, Prostatic Neoplasms surgery, Retrospective Studies, Adenocarcinoma diagnosis, Magnetic Resonance Imaging methods, Prostatic Neoplasms diagnosis
- Abstract
Purpose: To determine the best features to discriminate prostate cancer from benign disease and its relationship to benign disease class and cancer grade., Materials and Methods: The institutional review board approved this study and waived the need for informed consent. A retrospective cohort of 70 patients (age range, 48-70 years; median, 62 years), all of whom were scheduled to undergo radical prostatectomy and underwent preoperative 3-T multiparametric magnetic resonance (MR) imaging, including T2-weighted, diffusion-weighted, and dynamic contrast material-enhanced imaging, were included. The digitized prostatectomy slides were annotated for cancer and noncancerous disease and coregistered to MR imaging with an interactive deformable coregistration scheme. Computer-identified features for each of the noncancerous disease categories (eg, benign prostatic hyperplasia [BPH], prostatic intraepithelial neoplasia [PIN], inflammation, and atrophy) and prostate cancer were extracted. Feature selection was performed to identify the features with the highest discriminatory power. The performance of these five features was evaluated by using the area under the receiver operating characteristic curve (AUC)., Results: High-b-value diffusion-weighted images were more discriminative in distinguishing BPH from prostate cancer than apparent diffusion coefficient, which was most suitable for distinguishing PIN from prostate cancer. The focal appearance of lesions on dynamic contrast-enhanced images may help discriminate atrophy and inflammation from cancer. Which imaging features are discriminative for different benign lesions is influenced by cancer grade. The apparent diffusion coefficient appeared to be the most discriminative feature in identifying high-grade cancer. Classification results showed increased performance by taking into account specific benign types (AUC = 0.70) compared with grouping all noncancerous findings together (AUC = 0.62)., Conclusion: The best features with which to discriminate prostate cancer from noncancerous benign disease depend on the type of benign disease and cancer grade. Use of the best features may result in better diagnostic performance., (© RSNA, 2015)
- Published
- 2016
- Full Text
- View/download PDF
17. A unique pancreatic tumor with exclusive hepatocytic differentiation.
- Author
-
Shih NN, Tsung JS, Yang AH, Tsou MH, and Cheng TY
- Subjects
- Adult, Antigens, Neoplasm analysis, Carcinoembryonic Antigen analysis, Carcinoma, Hepatocellular chemistry, Humans, Incidental Findings, Male, Pancreatic Neoplasms chemistry, Carcinoma, Hepatocellular pathology, Pancreatic Neoplasms pathology
- Abstract
Only 7 cases of pancreatic tumor with hepatocytic differentiation have been reported in the literature, including 6 cases of hepatoid carcinoma and one case of hepatoid adenoma. Diagnosis of hepatoid carcinoma depends on recognition of characteristic histological features, supported by other evidence linked to hepatic lineage including alpha-fetoprotein production, positive immunoreactivity to liver synthesized proteins, and in situ hybridization detection of albumin mRNA. In addition, a synchronous focus of carcinoma arising in pancreatic ducts, islet cells, or acinar cells is essential. We report a unique case of pancreatic tumor with exclusive hepatocytic differentiation. In this tumor, we were unable to find a synchronous focus of carcinoma arising in pancreatic ducts, islet cells, or acinar cells, ruling out the possibility of its being hepatoid carcinoma. Long term follow-up can help to determine whether this tumor is benign or malignant. The patterns of reticulin staining and immunohistochemical staining are suggestive of malignancy, but mitotic activity is low and nuclear pleomorphism is minimal.
- Published
- 2006
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.